AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLICAZIDE
5 registrations across 3 African markets— 2 active
Markets with GLICAZIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Gliclan 80mg tablets Tablet Uncoated | 🇿🇲Zambia | Fourrts (India) Laboratories (Pvt) Limited | active | Jul 2029 |
| DIAMEZID 60MG COMPRIME PELLICULE SECABLE A LIBERATION MODIFIEE BOITE DE 30 | 🇨🇮Côte d'Ivoire | OPALIA PHARMA S.A | expired | Jan 2023 |
| GEZID 80MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | ZYDUS LIFESCIENCES LIMITED | expired | Jan 2021 |
| GLICAMOL 80MG COMPRIME BOITE DE 10 | 🇨🇮Côte d'Ivoire | LABORATOIRE MOLCHEM LTD | expired | Jan 2020 |
| SULFAN comprimé / 80 mg | 🇸🇳Senegal | COOPER MAROC | active | — |
GLICAZIDE in Africa — Regulatory Overview
GLICAZIDE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 2 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.